MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income
$99,652K
Stock-based compensation
$84,500K
Proceeds from maturities
of marketable...
$389,576K
Accounts payable
$25,068K
Accrued and other
liabilities
$3,928K
Other assets
-$1,457K
Depreciation and
amortization
$1,149K
Long-term accrued income
taxes
$1,092K
Amortization of right-of-use
asset
$741K
Accrued research and
development expenses
$86K
Net cash provided by
operating activities
$141,996K
Net cash provided
(used in) by investing...
$69,758K
Net effect of
exchange rate changes on...
$1,442K
Canceled cashflow
$75,677K
Canceled cashflow
$319,818K
Net (decrease)
increase in cash and cash...
-$7,170K
Canceled cashflow
$213,196K
Proceeds from stock
option exercises, net...
$15,869K
Proceeds from purchases
under the employee...
$9,621K
Deferred income taxes
-$37,537K
Prepaid expenses and
other current assets
$18,917K
Inventory
$7,481K
Trade receivables
$5,810K
Accretion of discount on
marketable securities, net
$5,103K
Operating lease liability
-$829K
Purchases of marketable
securities
$319,607K
Purchases of property and
equipment
$211K
Net cash used in
financing activities
-$220,366K
Canceled cashflow
$25,490K
Repurchases of common stock
in connection with...
$172,915K
Cash paid to satisfy
statutory withholding...
$72,941K
Back
Back
Cash Flow
source: myfinsight.com
CORCEPT THERAPEUTICS INC (CORT)
CORCEPT THERAPEUTICS INC (CORT)